These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. INFLUENCE OF ADMINISTRATION OF METHYLANDROSTENEDIOL ON ELECTROPHEROGRAM OF SERUM PROTEINS IN C3HF VIRGIN MICE WITH EXPERIMENTAL MAMMARY CARCINOMA. STOLK A Acta Morphol Neerl Scand; 1964; 5():295-301. PubMed ID: 14121943 [No Abstract] [Full Text] [Related]
6. [Comparative study of local changes in connective tissue induced by testosterone propionate, dehydroepiandrosterone, methylandrostenediol and cholesterol]. RUBENS-DUVAL A; VILLIAUMEY J Ann Endocrinol (Paris); 1956 Oct; 17(5):637-41. PubMed ID: 13411661 [No Abstract] [Full Text] [Related]
7. Complications of testosterone therapy in the female; the use of methylandrostenediol as a substitute. ROBINSON WW Q Rev Surg; 1953 Sep; 10(3):163-5. PubMed ID: 13100620 [No Abstract] [Full Text] [Related]
8. [A new synthetic steroid, methylandrostenediol]. LAMARCA V Prog Med (Napoli); 1953 Feb; 9(3):78-83. PubMed ID: 13056051 [No Abstract] [Full Text] [Related]
9. Methylandrostenediol: a non-virilizing derivative of testosterone in metastatic cancer of the breast. HOMBURGER F; KASDON SC; FISHMAN WH Proc Soc Exp Biol Med; 1950 May; 74(1):162-4. PubMed ID: 15430420 [No Abstract] [Full Text] [Related]
10. Complications of testosterone therapy in the female; the use of methylandrostenediol as a substitute. ROBINSON WW West J Surg Obstet Gynecol; 1953 Feb; 61(2):79-82. PubMed ID: 13029453 [No Abstract] [Full Text] [Related]
11. [Inhibition of the estrogenic activity of methylandrostenediol following administration of aminopterin]. DE CICCO A; SALA F Boll Soc Ital Biol Sper; 1955; 31(9-10):1280-4. PubMed ID: 13329094 [No Abstract] [Full Text] [Related]
12. [Effects of a new methylandrostenediol derivative (methylandrostenediol 3-propionate) on protein anabolism]. MASSONS JM Rev Iber Endocrinol; 1955; 2(10):421-32. PubMed ID: 13290275 [No Abstract] [Full Text] [Related]
13. [Influence of the administration of testosterone, methylandrostenediol and 19-nortestosterone on urinary elimination of estrogens and corticoids]. SUARDI L Minerva Med; 1959 Oct; 50():3407-12. PubMed ID: 13835496 [No Abstract] [Full Text] [Related]
14. The long-term effect of some androgenic and anabolic hormones on circulating eosinophils. VANHA-PERTTULA TP Acta Endocrinol (Copenh); 1962 Sep; 41():107-15. PubMed ID: 13924741 [No Abstract] [Full Text] [Related]
15. [Changes in the vaginal smear in rats treated with testosterone propionate and methylandrostenediol]. BERLINGIERI D Arch Ostet Ginecol; 1959; 64():938-55. PubMed ID: 13799559 [No Abstract] [Full Text] [Related]
16. [Methylandrostenediol as a tissue building substance]. WISSMER B Helv Med Acta; 1952 Oct; 19(4-5):368-71. PubMed ID: 13021783 [No Abstract] [Full Text] [Related]
17. [Somatotropic activity of methylandrostenediol; clinical contribution]. PENDE V Folia Endocrinol Mens Incretologia Incretoterapia; 1953 Dec; 6(6):835-46. PubMed ID: 13151222 [No Abstract] [Full Text] [Related]
19. [Methylandrostenediol, its properties]. ROBERT J Sem Hop; 1953 Feb; 29(9):423-6. PubMed ID: 13076263 [No Abstract] [Full Text] [Related]
20. Effect of methylandrostenediol and its esters on protein anabolism. II.. KOLLER M; ERCOLI A Boll Soc Ital Biol Sper; 1953 Feb; 29(2):137-9. PubMed ID: 13081761 [No Abstract] [Full Text] [Related] [Next] [New Search]